|
Jack Steven Daubert, M.D., F.A.C.S.
Curriculum Vitae
Medical Offices |

|
|
1050 SE Monterey Road
Suite 104
Stuart, FL. 34994
(772) 283-2020
|
|
550 Heritage Drive
Suite 105
Jupiter, FL. 33458
(561) 839-2780
|
|
1515 N. Flagler Drive
Suite 500
West Palm Beach, FL. 33401
(561) 659-9700
|
| |
Board Certifications
July 1991 Diplomat, American Board of Ophthalmology
July 1986 Diplomat, National Board of Medical Examiners
Education
1981 – 1985 Jefferson Medical College
Philadelphia, PA
Degree: M.D.
1977 – 1981 Pennsylvania State University, Pennsylvania
Graduate: Summa Cum Laude
Phi Beta Kappa
Biology Major
Degree: Bachelor of Science
Post Doctoral Training
1991 – 1992 Vitreo-Retinal Fellow
Retina Associates
Boston, Massachusetts
1986 – 1989 Ophthalmology Residency
Washington Hospital Center
Washington National Eye Center
Washington, D.C.
1988 – 1989 Chief Ophthalmology Resident
Washington Hospital Center
Washington National Eye Center
Washington, D.C.
1985 – 1986 Surgical Internship
Washington Hospital Center
Washington, D.C.
1989 – 1990 Palm Beach Eye Clinic
130 Butler Street
West Palm Beach, FL
1992 – Present Jack Daubert, M.D., PA
Self-employed
Awards and Honors
2009 Top Doctor Award – Castle Connolly Medical, Ltd.
2008 Top Doctor Award – Castle Connolly Medical, Ltd.
2007 Top Doctor Award – Castle Connolly Medical, Ltd.
1989 Davis Cup Recipient for outstanding Scientific Research & Presentation
Washington National Eye Center
1988 Davis Cup Recipient for outstanding Scientific Research and Presentation
Washington National Eye Center
- Muller Memorial Award in Ophthalmology
- Phi Beta Kappa
- Graduated Summa Cum Laude
- Who’s Who Among Students in American Universities?
Professional Membership
Fellow American Academy of Ophthalmology
Fellow American College of Surgeons
American College of Surgeons
Florida Society of Ophthalmology
Florida Medical Society
Palm Beach Ophthalmology Society
Palm Beach Medical Society
American Society of Cataract & Refractive Surgery
Medical Licensure
Florida
Pennsylvania
Appointments
Attending Staff Good Samaritan Hospital
West Palm Beach, FL.
Attending Staff Martin Memorial Medical Center
Stuart, FL.
Attending Staff Palm Beach Gardens Medical Center
Palm Beach Gardens, FL.
Attending Staff Jupiter Medical Center
Jupiter, FL.
Publications and Original Reports
Daubert, J; E1-choufi, L; Stephens, R:
Laser Treatment of Subfoveolar Choroldal
Neovascular Membranes
Ophthalmic Surgery 1991; 22: 665-669
Stephens, R; Daubert, J; E1-choufl, L:
Visual Improvement after Four Laser Treatments
To Foveola for Choroldal Neovascular Membrane
Ophthalmic Surgery 1991; 22: 470-474
Daubert, J; Nik, N; Chandeyssoun, PA,; E1-choufi, L:
Tear Flow Analysis Through the Upper and Lower Systems
Ophthalmic Plastic Reconstructive Surgery 1990; 6(3): 193-196
Daubert, J; Bernanrdino, V
Conjunctival Nevl, Review of 350 cases
Wills Eye Hospital 1985
Clinical Trials
2008/09 Sub-Investigator, Genentech, FVF4165g, A Phase III, Double-Masked, Multi-Center, Randomized, Sham-Controlled Study of the Efficacy and Safety of Ranibizumab Injection Compared with Sham in Subjects with Macular Edema Secondary to Branch Retinal Vein Occlusion.
2008/09 Sub-Investigator, Genentech, FVF4166g, A Phase III, Double-Masked, Multi-Center, Randomized, Sham-Controlled Study of the Efficacy and Safety of Ranibizumab Injection Compared with Sham in Subjects with Macular Edema Secondary to Central Retinal Vein Occlusion.
2009/10 Sub-Investigator, Genentech, FVF4168g, A Phase III, Double-Masked, Multi-Center, Randomized, Sham-Controlled Study of the Efficacy and Safety of Ranibizumab Injection in Subjects with Clinically Significant Macular Edema with Center Involvement Secondary to Diabetes Mellitus
2009/10 Sub-Investigator, Regeneron Pharmaceuticals, Study VGFT-OD-0605 Version VGFT-OD-0605.1 A Randomized, Double Masked, Active Controlled Phase III Study of the Efficacy, Safety, and Tolerability of repeated Doses of Intravitreal VEGF Trap in Subjects with Neovascular Age-Related Macular Degeneration.
2008 Sub-Investigator, Allergan Protocol 206207-016: A 6-Month, Single-Masked, Multicenter, Randomized, Controlled Study to Assess the Safety and Efficacy of 700 µg Dexamethasone Posterior Segment Drug Delivery System Applicator System as Adjunctive Therapy to Lucentis® Compared with Lucentis® Alone in the Treatment of Patients with Choroidal Neovascularization.
|